420 related articles for article (PubMed ID: 27292523)
1. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
Schlieve T; Heidel RE; Carlson ER
J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
[TBL] [Abstract][Full Text] [Related]
3. Clinical analysis of second primary gingival squamous cell carcinoma after radiotherapy.
Fu X; Chen S; Chen W; Yang Z; Song M; Li H; Zhang H; Yao F; Su X; Liu T; Yang AK
Oral Oncol; 2018 Sep; 84():20-24. PubMed ID: 30115471
[TBL] [Abstract][Full Text] [Related]
4. Second primary lung cancers following a diagnosis of primary head and neck cancer.
Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
[TBL] [Abstract][Full Text] [Related]
5. Second primary cancers in the Vaud and Neuchâtel Cancer Registries.
Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C
Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586
[TBL] [Abstract][Full Text] [Related]
6. Synchronous and metachronous head and neck carcinomas.
Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M
Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.
Wang YK; Chuang YS; Wu TS; Lee KW; Wu CW; Wang HC; Kuo CT; Lee CH; Kuo WR; Chen CH; Wu DC; Wu IC
Int J Cancer; 2017 Nov; 141(10):1987-1996. PubMed ID: 28758200
[TBL] [Abstract][Full Text] [Related]
8. [Second primary tumors in head and neck cancer].
Alvarez Marcos CA; Llorente Pendás JL; Franco Gutiérrez V; Hermsen MA; Franco Albalad MP; Fernández Espina H; Suárez Nieto C
Acta Otorrinolaringol Esp; 2006 Dec; 57(10):462-6. PubMed ID: 17228646
[TBL] [Abstract][Full Text] [Related]
9. Effect of routine esophageal screening in patients with head and neck cancer.
Su YY; Chen WC; Chuang HC; Guo CS; Lin YT; Luo SD; Fang FM; Chien CY
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):350-4. PubMed ID: 23519755
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
[TBL] [Abstract][Full Text] [Related]
11. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
13. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
[TBL] [Abstract][Full Text] [Related]
14. Second primary tumors in patients with head and neck squamous cell carcinoma.
Jones AS; Morar P; Phillips DE; Field JK; Husband D; Helliwell TR
Cancer; 1995 Mar; 75(6):1343-53. PubMed ID: 7882285
[TBL] [Abstract][Full Text] [Related]
15. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
16. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience.
Al-Wassia R; Vakilian S; Holly C; Sultanem K; Shenouda G
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):31. PubMed ID: 26330008
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
19. Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.
Kim SA; Moon H; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Clin Transl Oncol; 2017 Jul; 19(7):826-833. PubMed ID: 28093700
[TBL] [Abstract][Full Text] [Related]
20. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]